Ponatinib
AP24534-12-202
Phase 2 small_molecule completed
Quick answer
Ponatinib for GIST is a Phase 2 program (small_molecule) at Takeda with 1 ClinicalTrials.gov record(s).
Program details
- Company
- Takeda
- Indication
- GIST
- Phase
- Phase 2
- Modality
- small_molecule
- Status
- completed